Methods of Synthesis and Bioactivity of 3-Carboxy-quinolin-4(1H)-ones

被引:0
作者
Putarov, Nathalia B. [1 ]
de Carvalho, Erika M. [2 ]
de Aguiar, Alcino P. [1 ]
机构
[1] Inst Mil Engn, Lab Sintese Organ, Secao Engn Quim, Praca Gen Tiburcio 80, BR-22290270 Rio De Janeiro, RJ, Brazil
[2] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos Farmanguinhos, Dept Sintese Organ, BR-21041250 Rio De Janeiro, RJ, Brazil
关键词
4(1H)-Quinolone; bioactivity; synthesis;
D O I
10.5935/1984-6835.20140027
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The 3-carboxy-quinolin-4(1H)-ones constitute an important group of antimicrobial agents widely used in treatment of several diseases. The nalidixic acid, the first quinolone derivative developed as antibacterial agent in the early 1960s, was used as prototype to this group improvement. However, these compounds were neglected until the development of fluoroquinolones. The research associated to these antibiotics has been developed since ciprofloxacin was employed in the late 1980s, and from that period on it has been object of study. The versatility of 3-carboxy -quinolin-4(1H)-ones is associated to their wide range of biological activities reported in the literature, such as: antibacterial, antiviral, antiprotozoal, antifungal, and antitumoral. This review gives a highlight to the main synthetic methodologies for the synthesis of these heterocycles: Gould-Jacobs, Grohe-Heitzer, Baylis-Hillman, reactions employing transition metals and solid-phase reactions. Additionally, examples of the influence of chiral substituents on antibacterial activity are presented.
引用
收藏
页码:374 / 395
页数:22
相关论文
共 76 条
[1]  
Adrio J, 1999, HETEROCYCLES, V51, P1563
[2]  
Ahmed A, 2012, J PHARM PHARM SCI, V15, P52
[3]   Microwave-Assisted Preparation of Quinolone and Quinoline Derivatives [J].
Albrecht, Markus ;
Osetska, Olga ;
Rantanen, Toni ;
Froehlich, Roland ;
Bolma, Carsten .
SYNLETT, 2010, (07) :1081-1084
[4]   Topoisomerase IV-quinolone interactions are mediated through a water-metal ion bridge: mechanistic basis of quinolone resistance [J].
Aldred, Katie J. ;
McPherson, Sylvia A. ;
Turnbough, Charles L., Jr. ;
Kerns, Robert J. ;
Osheroff, Neil .
NUCLEIC ACIDS RESEARCH, 2013, 41 (08) :4628-4639
[5]   The quinolones: Past, present, and future [J].
Andriole, VT .
CLINICAL INFECTIOUS DISEASES, 2005, 41 :S113-S119
[6]   The fluoroquinolone antibacterials: past, present and future perspectives [J].
Appelbaum, PC ;
Hunter, PA .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 16 (01) :5-15
[7]  
Arbex M.A., 2010, REV VIRTUAL QUIMICA, V36, P641
[8]   Palladium-based innovative catalytic procedures: Designing new homogeneous and heterogeneous catalysts for the synthesis and functionalisation of N-containing heteroaromatic compounds [J].
Batail, Nelly ;
Genelot, Marie ;
Dufaud, Veronique ;
Joucla, Lionel ;
Djakovitch, Laurent .
CATALYSIS TODAY, 2011, 173 (01) :2-14
[9]  
Brighty K.E, 1991, US, Patent No. [CA 5162402, 5162402]
[10]  
Brouet Jean-Cristophe, 2009, Synth Commun, V39, P5193